What is the current price and session status of ORPOF stock?

ORPOF stock trades at **$11.60** during market hours on 25 Feb 2026, with **volume 748** and an average volume of **611**, indicating light trading activity.

How does Meyka AI rate ORPOF stock and what does it mean?

Meyka AI rates ORPOF with a score out of 100 at **63.78 (B, HOLD)**. The grade considers benchmark and sector comparisons, growth, key metrics, and analyst signals. It is informational, not investment advice.

What are realistic price targets for ORPOF stock?

Conservative target **$9.00** (implied -22.41%), base target **$12.50** (implied +7.76%), bull target **$16.00** (implied +37.93%). Targets assume varying clinical or partnership outcomes.

What short-term trading setup suits ORPOF stock?

An oversold bounce setup works: look for reversal volume, entry on weakness with a stop under **$10.40**, and partial profit taking near **$13.80** to manage binary biotech risk.

US Stocks

25 Feb 2026 ORPOF OSE (PNK) $11.60 market: oversold bounce entry

ByHuzaifa Zahoor February 25, 2026

ORPOF stock trades at $11.60 on 25 Feb 2026 during U.S. market hours, marking a low-volume setup for an oversold bounce. The PNK-listed OSE Immunotherapeutics (United States, USD) shows a thin float with volume 748 and avgVolume 611, which can amplify short-term swings. Investors using an oversold bounce strategy should weigh the biotech pathway milestones, upcoming earnings date 2026-03-26, and current valuation metrics before entering.